Wall Street Experts
ver. ZuMIgo(08/25)
HOB Biotech Group Corp.,Ltd
Rachunek Zysków i Strat
Przychody TTM (mln): 398
EBIT TTM (mln): 45
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
Rok finansowy |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
112 |
146 |
201 |
259 |
222 |
318 |
320 |
394 |
402 |
Przychód Δ r/r |
0.0% |
31.1% |
37.7% |
28.6% |
-14.4% |
43.2% |
0.8% |
23.1% |
2.0% |
Marża brutto |
65.6% |
69.7% |
70.6% |
68.1% |
65.6% |
69.0% |
63.1% |
62.1% |
63.9% |
EBIT (mln) |
3 |
25 |
49 |
70 |
65 |
98 |
48 |
56 |
41 |
EBIT Δ r/r |
0.0% |
681.5% |
100.0% |
42.5% |
-7.1% |
49.8% |
-51.2% |
17.4% |
-25.9% |
EBIT (%) |
2.8% |
16.8% |
24.4% |
27.0% |
29.3% |
30.7% |
14.8% |
14.2% |
10.3% |
Koszty finansowe (mln) |
2 |
2 |
2 |
1 |
2 |
1 |
2 |
3 |
3 |
EBITDA (mln) |
11 |
34 |
66 |
88 |
83 |
125 |
81 |
99 |
89 |
EBITDA(%) |
10.2% |
23.5% |
32.7% |
34.1% |
37.3% |
39.4% |
25.2% |
25.0% |
22.1% |
Podatek (mln) |
-0 |
3 |
7 |
10 |
8 |
13 |
5 |
9 |
4 |
Zysk Netto (mln) |
4 |
21 |
40 |
64 |
57 |
86 |
42 |
47 |
37 |
Zysk netto Δ r/r |
0.0% |
392.6% |
88.0% |
59.0% |
-11.3% |
52.2% |
-51.7% |
13.6% |
-22.2% |
Zysk netto (%) |
3.9% |
14.6% |
19.9% |
24.6% |
25.5% |
27.1% |
13.0% |
12.0% |
9.1% |
EPS |
0.0954 |
0.47 |
0.88 |
1.01 |
0.9 |
1.37 |
0.66 |
0.75 |
0.59 |
EPS (rozwodnione) |
0.0954 |
0.47 |
0.88 |
1.01 |
0.9 |
1.37 |
0.66 |
0.74 |
0.59 |
Ilośc akcji (mln) |
45 |
45 |
46 |
63 |
63 |
63 |
63 |
63 |
62 |
Ważona ilośc akcji (mln) |
45 |
45 |
46 |
63 |
63 |
63 |
63 |
64 |
63 |
Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |